UK approves AstraZeneca COVID therapy

The British Medicines Regulator has approved AstraZeneca’s antibody treatment for COVID-19 for immunocompromised adults, a major step in the fight against the pandemic as infections rise worldwide amid the rise of the Omicron variant.

Share this post:

Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner